Guozheng Liu Selected Research

Guozheng Liu Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 03/2002
4	Infections 01/2016 - 07/2004
2	Stroke (Strokes) 07/2022 - 01/2021
1	Renal Insufficiency (Renal Failure) 07/2022
1	Ischemic Stroke 07/2022
1	Cerebral Infarction 01/2021
1	Pneumonia (Pneumonitis) 10/2020
1	Dehydration (Water Stress) 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2016
1	Flatulence 01/2016
1	Bacterial Infections (Bacterial Infection) 11/2013
1	Mycoses (Diseases, Fungus) 01/2013
1	Fungal Lung Diseases 01/2013
1	Chronic Renal Insufficiency 01/2012
1	Colonic Neoplasms (Colon Cancer) 08/2007
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Inflammation (Inflammations) 07/2004
1	Neoplasm Metastasis (Metastasis) 05/2002

Drug/Important Bio-Agent (IBA)

7	MorpholinosIBA 11/2013 - 03/2002
5	tumor-associated antigen 72IBA 01/2014 - 08/2007
5	Peptides (Polypeptides)IBA 10/2011 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 08/2006
3	Ribosomal RNAIBA 01/2016 - 01/2013
3	AntigensIBA 01/2014 - 05/2008
3	StreptavidinIBA 01/2012 - 03/2002
3	A-Form DNA (A-DNA)IBA 02/2011 - 03/2002
3	CY5.5 cyanine dyeIBA 07/2010 - 01/2007
2	Alkaline PhosphataseIBA 07/2022 - 10/2020
2	PolymersIBA 09/2015 - 06/2004
2	Biotin (Vitamin H)FDA Link 01/2012 - 03/2002
2	Glycoproteins (Glycoprotein)IBA 10/2011 - 08/2007
2	Messenger RNA (mRNA)IBA 02/2011 - 06/2009
2	AvidinIBA 12/2010 - 03/2002
2	Chelating AgentsIBA 07/2010 - 05/2008
2	OligonucleotidesIBA 06/2009 - 01/2007
2	4-(N-maleimido)benzyltrimethylammonium (MPTA)IBA 05/2008 - 02/2008
1	polybis(carbophenoxypropane) (PCPP)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Long Noncoding RNAIBA 01/2019
1	Aquaporins (Water Channels)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	16S Ribosomal RNAIBA 11/2013
1	CholesterolIBA 01/2012
1	AminesIBA 12/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2011
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2010
1	Trastuzumab (Herceptin)FDA Link 07/2010
1	B72.3 antibodyIBA 05/2008
1	AntibodiesIBA 05/2008
1	Complementary DNA (cDNA)IBA 11/2007
1	Antisense DNAIBA 11/2007
1	Antisense OligonucleotidesIBA 01/2007
1	GuanineIBA 01/2007
1	CytosineIBA 03/2004
1	Radioisotopes (Radionuclides)IBA 12/2002
1	Cysteine (L-Cysteine)FDA Link 05/2002
1	cyclic arginine-glycine-aspartic acid peptideIBA 05/2002
1	Integrin alphaVbeta3IBA 05/2002
1	IntegrinsIBA 05/2002
1	Integrin beta3 (GPIIIa)IBA 05/2002

Therapy/Procedure

6	Radiotherapy 01/2012 - 08/2006
3	Therapeutics 01/2022 - 10/2010
3	Injections 05/2013 - 06/2004
1	Intravenous Injections 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Gastrectomy 01/2016
1	Length of Stay 01/2016
1	Intravenous Administration 02/2011
1	Gamma Cameras (Gamma Camera) 07/2010
1	Subcutaneous Injections 07/2004